Federico Garrido receives the Columela Award `Andalusia Research´
Professor Federico Garrido Torres-Puchol, a researcher at ibs.GRANADA, has received the Andalusian Research Award "Columela" for the area of health sciences, which was awarded last year.
In the fourth edition of this award, the career of this professional has been highlighted and his extensive experience in the field of immunology has been distinguished. His most important contributions have been in the field of Immunogenetics and the greater system of histocompatibility.
His work has been essential to improve the management of patients who receive organ transplants, reducing the probability of rejection. In addition, Garrido is internationally known for having discovered an escape mechanism for cancer cells to the immune response mediated by T lymphocytes: specifically, the loss of expression of antigen presenting proteins known as HLA molecules.
This recognition is accredited by a long scientific curriculum since he has published 350 articles in international journals, as prestigious as "Nature", "Immunology Today", "Cancer Immunology", "Immunotherapy" and "International J of Cancer".
Our History
Federico Garrido is a professor of Immunology at the University of Granada belonging to the Department of Biochemistry and Molecular Biology 3 and Immunology since 1990. He also directs the clinical laboratory of the Virgen de las Nieves University Hospital where 25 medical specialists, pharmacists, chemists and biologists are integrated. analytical response to the hospital and its health area in the specialties of clinical biochemistry, hematology, genetics and immunology.
In his research role, Professor Garrido is responsible for the research group “Immune Response and Cancer. Mechanisms of Escape to the Immonological Response” of the Biosanitary Research Institute of Granada.
His professional and scientific training began at the University of Granada where he did his doctoral thesis and has been completed at the Immunogenetics department of London Hospital Medical College and at the German Cancer Research Center (Deutsches Krebsforszchungzentrum, DKFZ) in Heidelberg.
He has been the first Spanish president of the European Society of Immunogenetics. He was also president of the Spanish Society of Immunology and a founding member of it. Professor Federico Garrido has also received the Health Sciences Technology Park / Caja Rural de Granada Foundation Award on genomics and cancer.
He has been principal investigator in the last ten years of 17 research projects financed by the European Community, the National Plan and FIS and the Junta de Andalucía. He has directed 88 doctoral theses in the field of cancer immunogenetics and immune escape mechanisms.
